From the Wires
The Cochlear™ Baha® System Continues to Shape the Future of Bone Conduction Implant Technology
Cochlear Americas announces the next generation of Baha technology - the new Cochlear Baha BIA400 Implant
By: PR Newswire
Nov. 19, 2012 09:02 PM
CENTENNIAL, Colo., Nov. 19, 2012 /PRNewswire/ -- Cochlear Americas announced today the introduction of the Cochlear Baha BIA400 series, which features a unique abutment surface technology – a hydroxyapatite layer – that enables a tight adherence between the soft tissue and the abutment. This technology is designed to minimize the need for soft tissue removal and simplify the surgical procedure.
Important benefits for patients are that the surgical procedure becomes less invasive and the soft tissue disruption can be minimized. This new technology is designed to provide bone conduction patients with better aesthetic outcomes than with conventional percutaneous abutments. Leaving the soft tissue intact may also result in significantly shorter surgery time, faster healing and increase the likelihood of normal post-operative skin sensation around the implant site.
"As the first bone conduction implant company, we continue to innovate our solutions to better meet the needs of our recipients. We see the introduction of the BIA400 as a natural step in our continuous effort to improve the outcomes for our users," said Anthony Manna, President of Cochlear Bone Anchored Solutions.
The Cochlear Baha BA400 Abutment was recently cleared for use in the United States and Canada by the US Food and Drug Administration (FDA) and Health Canada, respectively. The BIA400 series is currently being introduced to these markets through a controlled market release, and is expected to be widely available to clinicians in early 2013.
About Bone Anchored Hearing Solutions
SOURCE Cochlear Americas
SOA World Latest Stories
Subscribe to the World's Most Powerful Newsletters
Subscribe to Our Rss Feeds & Get Your SYS-CON News Live!
SYS-CON Featured Whitepapers
Most Read This Week